Literature DB >> 8575535

Aldosterone inhibits nitric oxide synthesis in rat vascular smooth muscle cells induced by interleukin-1 beta.

U Ikeda1, T Kanbe, I Nakayama, Y Kawahara, M Yokoyama, K Shimada.   

Abstract

We investigated the effects of aldosterone on nitric oxide (NO) synthesis in vascular smooth muscle cells. We measured the production of nitrite, a stable metabolite of NO, and the expression of inducible NO synthase mRNA and protein in cultured rat vascular smooth muscle cells. Incubation of the cultures with interleukin-1 beta (10 ng/ml) for 24 h caused a significant increase in nitrite generation. The interleukin-1 beta-induced nitrite production by vascular smooth muscle cells was significantly inhibited by aldosterone in a dose (10(-9) approximately 10(-6) M)-dependent manner. Incubation with interleukin-1 beta for 12 approximately 24 h caused inducible NO synthase mRNA expression in vascular smooth muscle cells, whereas aldosterone had a suppressive effect on its expression. Aldosterone also decreased interleukin-1 beta-induced NO synthase protein accumulation. These results indicate that aldosterone inhibits NO synthesis under interleukin-1 beta-stimulated conditions in vascular smooth muscle cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8575535     DOI: 10.1016/0922-4106(95)90018-7

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  14 in total

Review 1.  Aldosterone and vascular damage.

Authors:  D Duprez; M De Buyzere; E R Rietzschel; D L Clement
Journal:  Curr Hypertens Rep       Date:  2000-06       Impact factor: 5.369

Review 2.  Aldosterone antagonists in the treatment of hypertension and target organ damage.

Authors:  S Rajagopalan; B Pitt
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

3.  Aldosterone predicts major adverse cardiovascular events in patients with acute myocardial infarction.

Authors:  Matthew Fomonyuy Yuyun; Sandeep K Jutla; Paulene A Quinn; Leong L Ng
Journal:  Heart Asia       Date:  2012-08-24

4.  Effects of aldosterone and related steroids on LPS-induced increased expression of inducible NOS in rat aortic smooth muscle cells.

Authors:  V Godfrey; A L Martin; A D Struthers; G A Lyles
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

Review 5.  Aldosterone receptor blockade in the management of heart failure.

Authors:  Emiliano A Palmieri; Bernadette Biondi; Serafino Fazio
Journal:  Heart Fail Rev       Date:  2002-04       Impact factor: 4.214

6.  Reduction of aldosterone production improves renal oxidative stress and fibrosis in diabetic rats.

Authors:  Luis C Matavelli; Helmy M Siragy
Journal:  J Cardiovasc Pharmacol       Date:  2013-01       Impact factor: 3.105

7.  Increased aortic stiffness elevates pulse and mean pressure and compromises endothelial function in Wistar rats.

Authors:  Xiaomei Guo; Xiao Lu; Junrong Yang; Ghassan S Kassab
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-07-18       Impact factor: 4.733

8.  Aldosterone induces endothelial dysfunction in resistance arteries from normotensive and hypertensive rats by increasing thromboxane A2 and prostacyclin.

Authors:  F E Xavier; R Aras-López; I Arroyo-Villa; L del Campo; M Salaices; L V Rossoni; M Ferrer; G Balfagón
Journal:  Br J Pharmacol       Date:  2008-05-26       Impact factor: 8.739

9.  Renoprotection, renin inhibition, and blood pressure control: the impact of aliskiren on integrated blood pressure control.

Authors:  Haroon-Ur Rashid
Journal:  Integr Blood Press Control       Date:  2010-10-05

10.  Mineralocorticoid receptor antagonist pretreatment to MINIMISE reperfusion injury after ST-elevation myocardial infarction (the MINIMISE STEMI Trial): rationale and study design.

Authors:  Heerajnarain Bulluck; Georg M Fröhlich; Shah Mohdnazri; Reto A Gamma; John R Davies; Gerald J Clesham; Jeremy W Sayer; Rajesh K Aggarwal; Kare H Tang; Paul A Kelly; Rohan Jagathesan; Alamgir Kabir; Nicholas M Robinson; Alex Sirker; Anthony Mathur; Daniel J Blackman; Cono Ariti; Arvindra Krishnamurthy; Steven K White; Pascal Meier; James C Moon; John P Greenwood; Derek J Hausenloy
Journal:  Clin Cardiol       Date:  2015-05       Impact factor: 2.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.